Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study. Hwang TJ, Hediger S, Krishnan A, Cai CL, et al. Lancet 2026 Sep 13:S0140-6736(26)01555-2. doi: 10.1016/S0140-6736(26)01555.

Read + Share

Amedeo Smart

Independent Medical Education

Hwang TJ, Hediger S, Krishnan A, Cai CL, et al. Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study. Lancet 2026 Sep 13:S0140-6736(26)01555-2. doi: 10.1016/S0140-6736(26)01555.
PMID: 42732769